B cell immunodominance in primary hepatitis C virus infection.

•Neutralising antibodies will likely form a key component of an HCV vaccine.•We characterise the immunodominance of neutralising and non-neutralising epitopes in primary HCV infection.•We identify that virus genotype might influence the epitopes targeted.•We also identify that certain epitope target combinations are associated with greater breadth.